Alligator Bioscience AB Publishes Q1 2025 Financial Results and Business Update
Alligator Bioscience AB Reports Financial Results for Q1 2025 and Provides a Business Update LUND, SE / ACCESS Newswire / April 24, 2025 / Alligator Bioscience (STO:ATORX) 24-month data from OPTIMIZE-1 show 29.4% survival rate for mitazalimab-three times higher than chemotherapy alone FDA alignment secured on Phase 3 strategy following successful End-of-Phase 2 meeting Rights […]